Calcium Checks cyclic AMP - Corticosteroid feedback in adenohypophysial corticotrophs

Journal of Neuroendocrinology

Volumn 8, Issue 9, 1996, Pages 659-672

  Antoni, Ferenc A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adenylyl cyclase; Adrenocorticotrophic hormone; Calcium binding patterns; Calcium activated potassium currents; Corticotrophin releasing factor; Glucocorticoid; Membrane potential; Stress response

Indexed keywords

ADENYLATE CYCLASE; CALCINEURIN; CALCIUM BINDING PROTEIN; CALCIUM ION; CALMODULIN; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOTROPIN; CYCLIC AMP; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PHOSPHODIESTERASE; POTASSIUM CHANNEL; CALCIUM;

ADENOHYPOPHYSIS; ANIMAL CELL; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; ENZYME INHIBITION; FEEDBACK SYSTEM; HORMONE RELEASE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; STRESS; TUMOR CELL; ANIMAL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CALCIUM; CYCLIC AMP; FEEDBACK; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; PITUITARY-ADRENAL SYSTEM; STRESS;

EID: 0030226782     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.1996.tb00703.x     Document Type: Review

References (153)

1. Bondy PK. Disorders of the adrenal cortex. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology, Philadelphia: W. B. Saunders & Co. 1985: 816-890.
2. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5: 25-44.
3. de Kloet ER. Steroids, stability and stress. Front Neuroendocrinol 1984; 15: 416-425.
4. Mason D. Genetic variation in the stress response susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunology Today 1991; 12: 57-60.
5. Jones MT, Gillham B. Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol Rev 1988; 68: 743-818.
6. Dallman MF, Akana SF, Cascio CS, Darlington DM, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Rec Prog Horm Res 1988; 43: 113-173.
7. Dallman MF, Levin N, Cascio CS, et al. Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via Type I corticosterone receptors. Endocrinology 1989; 124: 2844-2849.
8. Dallman MF, Akana SF, Scribner K, et al. Stress, feedback and facilitation on the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 1992; 4: 517-526.
9. Kwak SP, Patel PD, Thompson RC, et al. 5′-Heterogeneity of the mineralocorticoid receptor messenger-ribonucleic-acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 1993; 133: 2344-2350.
10. Bamberger CM, Bamberger AM, de Castro M, et al. Glucocorticoid receptor-beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Inv 1995; 95: 2435-2441.
11. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-839.
12. Smith DF, Toft DO. Steroid receptors and their associated proteins. Mol Endocrinol 1993; 7: 4-11.
13. Moore DD. Promiscuous behaviour in the steroid hormone receptor superfamiy. Trends Neurosci 1989; 12: 165-168.
14. Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995; 83: 851-857.
15. Funder JW, Pearce PT, Smith Ret al. Mineralocorticoid action-target tissue-specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-585.
16. Krozowski Z, Albiston AL, Obeyesekere VR, et al. The human 11-beta hydroxysteroid dehydrogenase type II enzyme - comparisons with other species and localization to the distal nephron. J Ster Biochem Mol Biol. 1995; 55: 457-464.
17. Stewart PM, Wallace AM, Valentino R, et al. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; ii: 821-823.
18. Seckl JR, Dow RC, Low SC, et al. The 11 β-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. J Endocrinol 1993; 136: 471-477.
19. Perrot-Applanat M, Racadot O, Milgrom E. Specific localization of plasma corticosteroid-binding globulin immunoreactivity in pituitary corticotrophs. Endocrinology 1984; 115: 559-569.
20. Hammond GL. Potential functions of plasma steroid-binding proteins. Trends Endo Metab 1995; 6: 298-304.
21. Schüle R, Evans RM. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet 1991; 7: 377-381.
22. Trapp T, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharm Sci 1996; 17: 145-149.
23. Jonat C, Rahmsdorf HJ, Park K-K, et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189-1204.
24. Marx J. How the glucocorticoids suppress immunity. Science 1995; 270: 232-233.
25. Diamond MI, Miner JN, Yoshinaga SK, et al. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266-1272.
26. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993; 259: 1161-1165.
27. Shipston MJ, Antoni FA. Inactivation of early glucocorticoid feedback by corticotropin-releasing factor in vitro. Endocrinology 1992; 130: 2213-2218.
28. Autelitano DJ, Sheppard KE. Corticotrope responsiveness to glucocorticoids is modulated via rapid CRF-mediated induction of the proto-oncogene c-fos. Mol Cell Endocrinol 1993; 94: 111-119.
29. Keller-Wood MB, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1994; 5: 1-23.
30. Eberwine J, Jonassen J, Evinger M, et al. Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cell cultures. DNA 1987; 6: 483-492.
31. Roberts JL, Lundblad JR, Eberwine JH, et al. Hormonal regulation of POMC gene expression in pituitary. Ann N Y Acad Sci 1987; 512: 275-285.
32. Phillips MA, Tashjian Jr AH. Characterisation of an early inhibitory effect of glucocorticoids on stimulated adrenocorticotropin and endorphin release from a clonal strain of mouse pituitary cells. Endocrinology 1982; 110: 892-900.
33. Lambert JJ, Peters JA, Sturgess NC, et al. Steroid modulation of the GABA-A receptor complex: electrophysiological studies. In: Chadwick D, Widdows K, eds. Steroids and Neuronal Activity. Ciba Foundation Symposium 1990: 56-71.
34. Hallahan C, Young DA, Munck A. Time course of early events in the action of glucocorticoids on rat thymus cells in vitro. J Biol Chem 1973; 218: 2922-2927.
35. Dayanithi G, Antoni FA. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by Type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 1989; 125: 308-313.
36. Orchinnik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science 1991; 252: 1848-1850.
37. Wehling M. Nongenomic actions of steroid-hormones. Trends Endo Metab 1994; 5: 347-353.
38. Firestone GL, Payvar F, Yamamoto KR. Glucocorticoid regulation of protein processing and comparmentalization. Nature 1982; 300: 221-225.
39. Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms and physiological significance. Perspect Biol Med 1971; 14: 265-289.
40. Sapolsky RM. The physiological relevance of glucocorticoid endangermant of the hippocampus. Ann N Y Acad Sci 1994; 746: 294-307.
41. Bennett MC, Mlady GW, Fleshner M, Rose GM. Synergy between chronic corticosterone and sodium-azide treatments in producing a spatial-learning deficit and inhibiting cytochrome-oxidase activity. Proc NatI Acad Sci USA 1996; 93: 1330-1334.
42. Sloviter RS, Valiquette G, Abrams GM, et al. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 1989; 243: 535-538.
43. Azmitia EC, Liao B. Dexamethasone reverses adrenalectomy-induced neuronal de-diferentiation in midbrain raphe-hippocampus. Ann N Y Acad Sci 1994; 746: 180-194.
44. Meyer JS. Biochemical effects of the corticosteroids on neural tissues. Physiol Rev 1985; 65: 946-1020.
45. Joës M, de Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain implications for ion permeability and transmitter systems. Prog Neurobiol 1994; 43: 1-36.
46. Furth J, Gadsden EL, Upton AC. ACTH secreting transplantable pituitary tumors. Proc Soc Exp Biol Med 1953; 84: 253-254.
47. Yasumura Y. Retention of differentiated function in clonal animal cell lines particularly hormone-secreting cultures. Am Zool 1968; 8: 285-305.
48. Tashjian Jr. AJ. Clonal strains of hormone producing pituitary cells. Meth Enzymol 1979; 58: 527-535.
49. Suprenant A. Correlation between electrical activity and ACTH/-endorphin secretion in mouse pituitary tumor cells. J Cell Biol 1982; 95: 559-566.
50. Adler M, Wong BS, Sabol SL, et al. Action potentials and membrane ion channels in clonal anterior pituitary cells. Proc Natl Acad Sci USA 1983; 80: 2086-2090.
51. Reisine T. Phorbol esters and corticotropin-releasing factor stimulate calcium influx in the anterior pituitary tumor cell line, AtT-20, through different intracellular sites of action. J Pharmacol Exp Ther 1989; 248: 1984-1990.
52. Shipston MJ, Kelly JS, Antoni FA. Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. J Biol Chem 1996; 271: 9197-9200.
53. Antoni FA. Hypothalamic regulation of adrenocorticotropin secre tion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7: 351-378.
54. Chalmers DT, Lovenberg TW, de Souza EB. Localization of novel corticotropin-releasing factor-receptor (CRF(2)) messenger-RNA expression to specific subcortical nuclei in rat-brain - comparison with CRF(1) receptor messenger-RNA expression. J Neurosci 1995; 15: 6340-6350.
55. Pozzoli G, Bilezikjian LM, Perrin MH, et al. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type-1 CRF receptor messenger-ribonucleic acid in rat anterior-pituitary cell cultures. Endocrinology 1996; 137: 65-71.
56. Vita N, Laurent P, Lefort S, et al. Primary structure and functional expression of mouse pituitary and human brain corticotropin-releasing factor receptors. FEBS Lett 1993; 335: 1-5.
57. Xiong YT, Xie LY, AbouSamra AB. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors decreased coupling efficiency of human type-II CRF receptor. Endocrinology 1995; 136: 1828-1834.
58. Reisine T, Rougon G, Barbet J, et al. Corticotropin releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP dependent protein kinase into anterior pituitary tumor cells by liposomes. Proc Natl Acad Sci USA 1985; 82: 8261-8265.
59. Schecterson LC. McKnight GS. Role of cyclic adenosine 3′,5′-monophosphate-dependent protein-kinase in hormone-stimulated β-endorphin secretion in AtT20 cells. Mol Endocrinol 1993; 5: 170-178.
60. Antoni FA. Vasopressinergic control of anterior pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
61. Gigure V, Labrie F, Côté J, et al. Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat: Site of glucocorticoid action. Proc Natl Acad Sci USA 1982; 79: 3466-3469.
62. Lutz-Bucher B, Flix JM, Koch B. Activation of protein kinase C differentially regulates corticotropin-releasing factor stimulated peptide secretion and cyclic AMP formation of intermediate and anterior pituitary cells in culture. Peptides 1990; 11: 1183-1189.
63. Woods MD, Shipston MJ, Mullens EL, el al. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids. Endocrinology 1992; 131: 2873-2880.
64. Svec F, Harrison RW. The intracellular distribution of natural and synthetic glucocorticoid in the AtT20 cell. Endocrinology 1979; 104: 1563-1568.
65. Antoni FA, Woods MD. Depolarisation of the membrane-potential antagonizes early-onset glucocorticoid inhibition of pituitary adrenocorticotrophin release in vitro. Abstr of the 8th Int Conf. on Second Messengers and Phosphoproteins, Glasgow. 1992: Q95F.
66. Woods MD, Shipston M, McFerran B, et al. Early glucocorticoid inhibition of hormone release in pituitary corticotrope cells is voltage-dependent. Ann N Y Acad Sci 1994; 746: 457-459.
67. Kraicer J, Milligan JV, Gosbee JL, et al. In vitro release of ACTH: Effects of potassium, calcium and corticosterone. Endocrinology 1969; 85: 1144-1153.
68. Antoni FA, Dayanithi G. Evidence for distinct glucocorticoid and guanine 3′,5′ monophosphate effected inhibition of secretagogue stimulated ACTH release in vitro. Endocrinology 1990; 126: 1355-1360.
69. Clark TP, Kemppainen RJ. Glucocorticoid negative feedback in sheep corticotrophs: a comparison with AtT-20 cortictroph tumor cells. Am J Physiol 1994; 36: R463-R469.
70. Antoni FA, Dayanithi G. Blockage of K+ channels reverses the inhibition of secretagogue stimulated ACTH release by atriopeptin. J Endocrinol 1990; 126: 183-191.
71. +, corticotropin-releasing factor and angiotensin II. Endocrinology 1987; 121: 395-405.
72. Hille B. Ionic channels of excitable membranes. Sinauer, New York.
73. Marchetti C, Childs GV, Brown AM. Membrane currents of identified isolated rat corticotropes and gonadotropes. Am J Physiol 1987; 252: E340-E346.
74. Gurineau N, Corcuff J-B, Tabarin A, et al. Spontaneous and corticotropin-releasing factor-induced cytosolic calcium transients in corticotrophs. Endocrinology 1991; 129: 409-420.
75. Halilimanabat C, Oki Y, Iino X, et al. The role of sodium in mediating adrenocorticotropin secretion by perifused rat anterior pituitary cells. Endocrinology 1995; 136: 2937-2942.
76. Childs GV, Marchetti C, Brown AM. Involvement of sodium channels and two types of calcium channels in the regulation of adrenocorticotropin release. Endocrinology 1987; 120: 2059-2069.
77. Mason WT, Waring DW. Patch clamp recordings of single ion channel activation by gonadotrophin-releasing hormone in ovine pituitary gonadotrophs. Neuroendocrinology 1986; 43: 205-219.
78. West JW, Numann R, Murphy BJ, et al. A phosphorylation site in the Na+ channel required for modulation by protein kinase C. Science 1991; 254: 866-868.
79. + channels and activation of protein kinases synergistically stimulate adrenocorticotrophin secretion by clonal mouse pituitary (AtT-20) tumour cells. J Endocrinol 1991; 129s: 253.
80. 2+]i and ACTH secretion in AtT20 cells. Mol Cell Endo 1994; 109: 11-18.
81. Leong DA. A complex mechanism of facilitation in pituitary ACTH cells: Recent single cells studies. J Exp Biol 1988; 139: 151-168.
82. Link H, Dayanithi G, Föhr KJ, Gratzl M. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively. Endocrinology 1992; 130: 2183-2191.
83. 2+ entry in corticotropes is partially dependent on protein kinase A. Endocrinology 1995; 136: 3925-3935.
84. Pennington A, Kelly JS, Antoni FA. Selective enhancement of an A type potassium current by dexamethasone in a corticotroph cell line. J Neuroendocrinol 1994; 6: 305-315.
85. Wong BS, Adler M. Tetraethylammonium blockade of calcium-activated potassium channels in clonal anterior pituitary cells. Pfluegers Arch 1986; 407: 279-284.
86. Pennefather PS, Heisler S, MacDonald JF. A potassium conductance contributes to the action of somatostatin-14 to suppress ACTH secretion. Brain Res 1988; 444: 346-350.
87. Antoni FA, Shipston MJ, Woods MD, et al. Secretagogue glucocorticoid interactions in the control of anterior pituitary adrenocorticotrophin (ACTH) secretion. In: Mornex R, Jaffiol C, Leclère J, eds. Progress in Endocrinology, Proceedings of the Ninth International Congress of Endocrinology, Nice. Carnforth, UK: Parthenon Publishers, 1992: 530-535.
88. Antoni FA, Hoyland J, Woods MD, et al. Glucocorticoid inhibition of stimulus-evoked adrenocorticotrophin release caused by suppression of intracellular calcium signals. J Endocrinol 1992; 133: RI3-R16.
89. Castellino F, Heuser J, Marchetti S, et al. Glucocorticoid stabilization of actin filaments: A possible mechanism for inhibition of corticotropin release. Proc Natl Acad Sci USA 1992; 89: 3775-3779.
90. Clark TP, Kemppainen RJ. Glucocorticoids do not affect intracellular calcium transients in corticotrophs: evidence supporting an effect distal to calcium influx. Neuroendocrinology 1994; 60: 273-282.
91. Link H, Dayanithi G, Gratzl M. Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients. Endocrinology 1993; 132: 873-878.
92. Antoni FA. Receptors mediating the CRH effects of vasopressin and oxytocin. Ann N Y Acad Sci 1987; 512: 195-204.
93. Chadio SE, Antoni FA. Specific oxytocin agonist stimulates prolactin release but has no effect on inositol phosphate accumulation in isolated rat anterior pituitary cells. J Mol Endocr 1993; 10: 107-114.
94. Schlosser SF, Almeida OFX, Patchev VK, et al. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the Vβ1 type. Endocrinology 1994; 135: 2058-2063.
95. Shipston MJ, Antoni FA. Early glucocorticoid feedback in anterior pituitary corticotrophs: Differential inhibition of hormone release induced by vasopressin and corticotrophin releasing factor in vitro. J Endocrinol 1991; 129: 261-267.
96. Shipston MJ, Antoni FA. Early glucocorticoid induction of calmodulin and its suppression by corticotropin-releasing factor in mouse corticotrope tumor (AtT20) cells. Biochem Biophys Res Commun 1992; 189: 1382-1388.
97. Shipston MJ. Mechanism and modulation of early glucocorticoid inhibition in anterior pituitary corticotrophs. PhD thesis. University of Edinburgh, Edinburgh, 1992.
98. Nojima H. Structural organisation of multiple rat calmodulin genes. J Mol Biol 1989; 208: 269-282.
99. Baughman G, Harrigan MT, Campbell NF, et al. Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol 1991; 5: 637-644.
100. Dowd DR, MacDonald PN, Komm BS, et al. Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis. J Biol Chem 1991; 266: 18423-18426.
101. Imai E, Miner JN, Mitchell JA, et al. Glucocorticoid receptor-cAMP response element-binding protein-interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993; 268: 5353-5356.
102. 2+ activated phosphatase in mammalian brain. Trends Neurosci 1989; 12: 117-122.
103. Lai Y, Peterson B, Catterall W. Selective dephosphorylation of the subunits of skeletal-muscle calcium channels by purified phosphoprotein phosphatases. J Neurochem 1991; 61: 1333-1339.
104. Liu JP, Engler D, Funder JW, et al. Arginine-vasopressin (AVP) causes the reversible phosphorylation of the myristoylated alanine-rich C-kinase substrate (MARCKS) protein in the ovine anteriorpituitary - Evidence that MARCKS phosphorylation is associated with adrenocorticotropin (ACTH) secretion. Mol Cell Endo 1994; 101: 247-256.
105. Schreiber SL. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 1992; 70: 365-368.
106. Shipston MJ, Hernando F, Barnard RJO, et al. Glucocorticoid negative feedback in pituitary corticotropes: pivotal role for calcineurin inhibition of adenylyl cyclase. Ann N Y Acad Sci 1994; 746: 453-456.
107. Czar MJ, Lyons RH, Welsh MJ, et al. Evidence that the FK506-binding immunophilin heat-shock-protein-56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 1995; 9: 1549-1560.
108. Sheppard KE. Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function. J Neuroendocrinol 1995; 7: 833-840.
109. Dumont FJ, Staruch MJ, Koprak SL, et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med 1992; 176: 751-760.
110. Antoni FA, Barnard RJO, Shipston MJ, et al. Calcineurin feedback inhibition of agonist-evoked cAMP formation. J Biol Chem 1995; 270: 28055-28061.
111. Paterson JM, Smith SM, Harmar AJ, et al. Control of a novel adenylyl cyclase by calcineurin. Biochem Biophys Res Commun 1995; 214: 1000-1007.
112. Nagasaka A, Ohkubo S, Hidaka H. 3′-5′-Cyclic-nucleotide phosphodiesterase in the bovine pituitary-gland. Biochim Biophys Acta 1983; 755: 481-487.
113. Toro MJ, Montoya E. Calcium dependent phosphodiesterase and its activator (calmodulin) in the rat anterior-pituitary. Acta Endocrinologica 1981; 97: 349-349.
114. Ewart RBL. Inhibition of anterior-pituitary cyclic-AMP phospho-diesterase by colchicine and vinblastine. FEBS Lett 1982; 141:25-28.
115. Antoni FA. Vasopressin and the endocrine response to stress. Neth J Zool 1995; 45: 98-102.
116. Guild S. Adenosine 3′:5′-cyclic monophosphate and guanine nucleotide effects on calcium-evoked ACTH release from electrically permeabilised AtT-20 cells. Br J Pharmacol 1991; 109: 117-122.
117. Stemmer P, Klee CB. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry (USA) 1994; 33: 6859-6866.
118. Sharma RK, Mooibroek M, Wang JH. Calmodulin-stimulated cyclic nucleotide phosphodiesterase isozymes. In: Cohen P, Klee CB, eds. Calmodulin Elsevier, Amsterdam: 1988: 265-295.
119. 2+/calcineurin inhibition of adenylyl-cyclase in mouse anterior-pituitary corticotroph tumor (AtT20) cells. J Physiol. 475p: 137-138.
120. Arimura A, Bowers CY, Schally AV, et al. Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro. Endocrinology 1969; 85: 300-311.
121. Portanova R, Sayers G. Corticosterone suppression of ACTH secretion: actinomycin D sensitive and insensitive components of the response. Biochem Biophys Res Commun 1974; 56: 928.
122. 2+ domains in Helix neurons. Neuron 1993; 10: 689-699.
123. 2+ current in excitable cells. Trends Pharm Sci 1996; 19: 35-43.
124. 2+ currents are found in bovine chromaffin cells: facilitation. J Physiol 1991; 432; 681-707.
125. Rougon G, Barbet J, Reisine T. Protein phosphorylation induced by phorbol esters and cyclic AMP in anterior pituitary cells: possible role in adrenocorticotropin release and synthesis. J Neurochem 1989; 52: 1270-1278.
126. Abou-Samra A-B, Catt KJ, Aguilera G. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures. Endocrinology 1989; 121: 965-971.
127. Antoni FA. Calcium inhibition of corticotropin releasing-factor-induced cAMP accumulation opposed by vasopressin in rat anterior pituitary cells. J Endocrinol. 1994; 143S: P5.
128. Plostky PM, Bruhn TO, Vale WW. Hypophyseotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 1985; 117: 323-329.
129. Canny BJ, Funder JW, Clarke IJ. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine-vasopressin in a stress- specific manner. Endocrinology 1989; 125: 2532-2539.
130. Caraty A, Grino M, Locatelli A, et al. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. J Clin Invest 1989; 85: 1716-1721.
131. Alexander SL, Irvine CHG, Ellis MJ, et al. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin and adrenocorticotropin as measured in pituitary venous blood from the horse. Endocrinology 1990; 128: 65-72.
132. von Bardeleben U, Holsboer F, Stalla GK, Müller OA. Combined administration of human corticotropin-releasing factor and lysine vasopressin induced cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 1991; 37: 1613-1618.
133. Scaccianoce S, Muscolo LAA, Cigliana G, et al. Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 1991; 128: 3138-3143.
134. Bilezikjian LM, Blount AL, Vale WW. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: Resistance to glucocorticoid action. Mol Endocrinol 1987; 1: 451-458.
135. Morrill AC, Wolf D, Levine MA, et al. Stress alters adenylyl cyclase activity in the pituitary and frontal cortex of the rat. Life Sci 1993; 53: 1719-1727.
136. B cyclic AMP phosphodiesterase, DPD (rPDE-IVB) and PDE-4 (rPDE-IVb) in brain: selective localization in membrane and cytosolic compartments and differential expession in various brain regions. Biochem J 1994; 304: 399-406.
137. Koch B, Lutz-Bucher B. Indirect relationship between vasopressin induced secretion of ACTH and cyclic nucleotides in cultured rat anterior pituitary cells. Eur J Pharmacology 1989; 159: 53-56.
138. Kumari M, Cover PO, Poyser RH, et al. Neuroendocrine responses to rolipram, denbufylline and 1,3-dicyclopropylmethyl-8-aminoxanthine (BRL 61063) in the rat. Br J Pharmacol 1993; 112: 322P.
139. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterease isozymes and the design of selective inhibitors. Trends Pharm Sci 1990; 11: 150-155.
140. Makara GB, Antoni FA, Stark E, et al. Hypothalamic organization of CRF containing structures. Neuroendocri Persp 1984; 3: 71-110.
141. Agnati L, Fuxe K, Yu Z-Y, et al. Morphometrical analysis of the distribution of corticotropin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactive structures in the paraventricular hypothalamic nucleus of the rat. Neurosci Lett 1985; 54: 147-152.
142. Kovács KJ, Kiss JZ, Makara GB. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin releasing factor (CRF) and arginine-vasopressin (AVP) immunostaining induced by adrenalectomy. Neuroendocrinology 1986; 44: 229-234.
143. Kasai M, Yamashita H. Cortisol suppresses noradrenaline-induced excitatory responses of neurons in the paraventricular nucleus; an in vitro study. Neurosci Lett 1988; 91: 65-70.
144. Kasai M, Yamashita H. Inhibition by cortisol of neurons in the paraventricular nucleus of the hypothalamus in adrenalectomized rats; an in vitro study. Neurosci Lett 1988; 91: 59-64.
145. Hu SB, Tannahill LA, Biswas S, et al. Release of corticotropin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture -response to activation of intracellular second messengers and to corticosteroids. J Endocrinol 1992; 132: 57-65.
146. 2+/calmodulin-stimulated activity in the hypothalamus. J Neuroendocrinol 1994; 6: 665-671.
147. Antoni FA, Palkovits M, Rosie R, et al. High levels of calcineurin inhibited adenylyl cyclase type 9 (AC9) in hippocampal projection neurons. Abstr Soc Neurosci 26th, Ann Meeting 1996.
148. Joëls M, de Kloet ER. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 1989; 245: 1502-1505.
149. Storm JF. Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells. J Physiol 1987; 385: 733-759.
150. Sah P, Isaacson JS. Channels underlying the slow afterhyperpolarization in hippocampal pyramidal neurons - neurotransmitters modulate the open probability. Neuron 1995; 15: 435-441.
151. Taylor A, Cowell A-M, Flower J, et al. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 1993; 58: 430-439.
152. Mangels LA, Gnegy ME. Carbachol stimulates binding of a photoreactive calmodulin derivative to calmodulin-binding proteins in intact SK-N-SH human neuroblastoma cells. J Biol Chem 1992; 267: 5847-5854.
153. 2+ , adenine nucleotide and calmodulin. J Biol Chem 1987; 262: 3065-3073.